Tenet Announces Results to Date of Its Tender Offer for 7.375% Senior Notes due 2013



DALLAS – August 17, 2010 – Tenet Healthcare Corporation (NYSE: THC) announced today that,
pursuant to the terms of its previously announced cash tender offer to purchase up to $800 million aggregate
principal amount of its outstanding 7.375% senior notes due 2013, $781.5 million aggregate principal
amount of the outstanding notes (approximately 78.3%) had been validly tendered prior to the expiration of
the early tender time of 5:00 p.m., New York City time, on August 16, 2010. The terms of the tender offer
are contained in an offer to purchase dated as of August 3, 2010 and a related letter of transmittal. The
tender offer will expire at 12:00 midnight, New York City time, on August 30, 2010.
Holders of notes that were validly tendered prior to the early tender time and that are accepted will
receive total consideration of $1,055 per $1,000 principal amount of notes, which includes an early tender
premium of $30 per $1,000 principal amount of notes, plus any accrued and unpaid interest up to, but not
including, the settlement date.
Holders of notes that are validly tendered after the early tender time, but prior to the expiration of
the tender offer, and accepted will receive the tender offer consideration of $1,025 per $1,000 principal
amount of notes, plus any accrued and unpaid interest up to, but not including, the settlement date. Holders
of notes tendered after the early tender time and accepted will not receive an early tender premium. Notes
tendered after the withdrawal deadline of 5:00 p.m., New York City time, on August 16, 2010 may not be
withdrawn except as required by law.
The aggregate principal amount of the notes to be purchased will be limited to $800 million. If the
aggregate principal amount of notes tendered exceeds the limit, any notes purchased will be prorated
pursuant to the terms of the offer to purchase. Tenet may amend, extend or terminate the tender offer in its
sole discretion.
2
This news release is neither an offer to purchase nor a solicitation of an offer to sell any notes. The
tender offer is being made pursuant to an offer to purchase and related letter of transmittal, copies of which
have been delivered to all holders of the notes. Persons with questions regarding the tender offer should
contact one of the following dealer managers — Barclays Capital at (800) 438-3242 (toll free) or (212) 528-
7581 (collect), BofA Merrill Lynch at (888) 292-0070 (toll free) or (980) 388-9217 (collect), Goldman,
Sachs & Co. at (800) 828-3182 (toll free) or (212) 902-5183 (collect) or Citi at (800) 558-3745 (toll free) —
or the Information Agent, Global Bondholder Services Corporation, at (866) 795-2200 (toll free) or (212)
430-3774 (collect).
Tenet Healthcare Corporation is a health care services company whose subsidiaries and affiliates
own and operate acute care hospitals, ambulatory surgery centers and diagnostic imaging centers. Tenet’s
hospitals and related health care facilities are committed to providing high quality care to patients in the
communities they serve.
# # #
Media:
Rick Black (469) 893-2647
[email protected]
Investors:
Thomas Rice (469) 893-2522
[email protected]
Some of the statements in this release may constitute forward-looking statements. Such statements are based
on our current expectations and could be affected by numerous factors and are subject to various risks and
uncertainties discussed in our filings with the Securities and Exchange Commission, including our annual report
on Form 10-K for the year ended Dec. 31, 2009, our quarterly reports on Form 10-Q and periodic reports on
Form 8-K. Do not rely on any forward-looking statement, as we cannot predict or control many of the factors
that ultimately may affect our ability to achieve the results estimated. We make no promise to update any
forward-looking statement, whether as a result of changes in underlying factors, new information, future events
or otherwise.